Yutaka Kobayashi - Publications

Affiliations: 
2013- Chemistry Baylor University, Waco, TX 

21 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Yamada T, Yagita M, Kobayashi Y, Sennari G, Shimamura H, Matsui H, Horimatsu Y, Hanaki H, Hirose T, Omura S, Sunazuka T. Synthesis and Evaluation of Antibacterial Activity of Bottromycins. The Journal of Organic Chemistry. PMID 29560726 DOI: 10.1021/Acs.Joc.8B00045  0.474
2017 Dhanjee HH, Kobayashi Y, Buergler JF, McMahon TC, Haley MW, Howell JM, Fujiwara K, Wood JL. Total Syntheses of (+)-and (-)-Tetrapetalones A and C. Journal of the American Chemical Society. PMID 28991468 DOI: 10.1021/Jacs.7B09358  0.665
2016 Dhanjee HH, Haley MW, McMahon TC, Buergler JF, Howell JM, Kobayashi Y, Fujiwara K, Wood JL. Synthetic studies toward tetrapetalone A: Attempted palladium π-allyl cascades toward a fused tricyclic intermediate Tetrahedron. DOI: 10.1016/J.Tet.2016.03.011  0.656
2012 Gouda H, Kobayashi Y, Yamada T, Ideguchi T, Sugawara A, Hirose T, Omura S, Sunazuka T, Hirono S. Three-dimensional solution structure of bottromycin A2: a potent antibiotic active against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococci. Chemical & Pharmaceutical Bulletin. 60: 169-71. PMID 22293474 DOI: 10.1248/Cpb.60.169  0.554
2010 Kobayashi Y, Ichioka M, Hirose T, Nagai K, Matsumoto A, Matsui H, Hanaki H, Masuma R, Takahashi Y, Omura S, Sunazuka T. Bottromycin derivatives: efficient chemical modifications of the ester moiety and evaluation of anti-MRSA and anti-VRE activities. Bioorganic & Medicinal Chemistry Letters. 20: 6116-20. PMID 20833545 DOI: 10.1016/J.Bmcl.2010.08.037  0.563
2009 Shimamura H, Gouda H, Nagai K, Hirose T, Ichioka M, Furuya Y, Kobayashi Y, Hirono S, Sunazuka T, Omura S. Structure determination and total synthesis of bottromycin A2: a potent antibiotic against MRSA and VRE. Angewandte Chemie (International Ed. in English). 48: 914-7. PMID 19115340 DOI: 10.1002/Anie.200804138  0.546
2003 Horie A, Hiki Y, Odani H, Yasuda Y, Takahashi M, Kato M, Iwase H, Kobayashi Y, Nakashima I, Maeda K. IgA1 molecules produced by tonsillar lymphocytes are under-O-glycosylated in IgA nephropathy. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. 42: 486-96. PMID 12955676 DOI: 10.1016/S0272-6386(03)00743-1  0.304
2003 Itoh A, Iwase H, Takatani T, Nakamura I, Hayashi M, Oba K, Hiki Y, Kobayashi Y, Okamoto M. Tonsillar IgA1 as a possible source of hypoglycosylated IgA1 in the serum of IgA nephropathy patients. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. 18: 1108-14. PMID 12748342 DOI: 10.1093/Ndt/Gfg108  0.3
2002 Aoyama T, Shimizu T, Matsuo T, Sakamoto H, Kamata K, Higashihara M, Tsuji H, Shigematsu H, Kobayashi Y. MPO-ANCA-positive slowly progressive glomerulonephritis with focal tuft necrosis and crescents. Internal Medicine (Tokyo, Japan). 41: 458-62. PMID 12135179 DOI: 10.2169/Internalmedicine.41.458  0.311
2002 Nakamura I, Iwase H, Ohba Y, Hiki Y, Katsumata T, Kobayashi Y. Quantitative analysis of IgA1 binding protein prepared from human serum by hypoglycosylated IgA1/Sepharose affinity chromatography. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 776: 101-6. PMID 12127330 DOI: 10.1016/S1570-0232(02)00176-9  0.322
2001 Kobayashi Y, Hiki Y, Sano T, Hashizume K, Matsuo T, Nakamura I, Sakamoto H, Tateno S. Prognostic significance of persistent massive proteinuria in IgA nephropathy: 10‐year follow‐up study of 366 cases Nephrology. 6. DOI: 10.1046/J.1440-1797.2001.00017.X  0.315
2001 Nakamura I, Iwase H, Hiki Y, Kobayashi Y. Quantitative analysis of IgA1 binding protein in human serum by hypoglycosylated IgA1/Sepharose chromatography Nephrology. 6. DOI: 10.1046/J.1440-1797.2001.00005.X  0.325
1997 Kobayashi Y, Hiki Y, Kokubo T, Sano T, Hashixume K, Tateno S. Steroid therapy in progressive IgA nephropathy: A 10 year follow‐up study Nephrology. 3: 739-745. DOI: 10.1111/J.1440-1797.1997.Tb00294.X  0.325
1996 Hiki Y, Iwase H, Saitoh M, Saitoh Y, Horii A, Hotta K, Kobayashi Y. Reactivity of Glomerular and Serum lgA1 to Jacalin in IgA Nephropathy Nephron. 72: 429-435. PMID 8852492 DOI: 10.1159/000188908  0.333
1994 Nomura M, Okada J, Tateno S, Kobayashi Y, Kondo H. Renal Thrombotic Microangiopathy in a Patient with Rheumatoid Arthritis and Antiphospholipid Syndrome: Successful Treatment with Cyclophosphamide Pulse Therapy and Anticoagulant Internal Medicine. 33: 484-487. PMID 7803916 DOI: 10.2169/Internalmedicine.33.484  0.314
1991 Tateno S, Hiki Y, Hamaguchi K, Tsuchida H, Shigematsu H, Kobayashi Y. Study of Lupus Nephritis in Males Qjm: An International Journal of Medicine. 81: 1031-1039. PMID 1808638 DOI: 10.1093/Qjmed/81.3.1031  0.332
1987 Tateno S, Kobayashi Y. Quantitative Analysis of Mesangial Areas in Serial Biopsied Patients with IgA Nephropathy Nephron. 46: 28-33. PMID 3600909 DOI: 10.1159/000184291  0.305
1986 Kobayashi Y, Fujii K, Hiki Y, Tateno S. Steroid therapy in IgA nephropathy: a prospective pilot study in moderate proteinuric cases. Qjm: An International Journal of Medicine. 61: 935-943. DOI: 10.1093/Oxfordjournals.Qjmed.A068052  0.301
1983 Kobayashi Y, Tateno S, Hiki Y, Shigematsu H. IgA Nephropathy: Prognostic Significance of Proteinuria and Histological Alterations Nephron. 34: 146-153. PMID 6348567 DOI: 10.1159/000183000  0.335
1983 Tateno S, Kobayashi Y, Shigematsu H, Hiki Y. Study of Lupus Nephritis: its Classification and the Significance of Subendothelial Depostis Qjm: An International Journal of Medicine. 52: 311-331. DOI: 10.1093/Oxfordjournals.Qjmed.A067764  0.32
1982 Kobayashi Y, Shigematsu H, Tateno S, Hiki Y. Nephrotic syndrome with diffuse mesangial IgM deposits. Pathology International. 32: 307-317. PMID 7046343 DOI: 10.1111/J.1440-1827.1982.Tb02051.X  0.309
Show low-probability matches.